Skip to content

Robotic Single Port Ventral Hernia Repair

Evaluation of SupraPubic Robotic Extraperitoneal Single-port Site Operation for Ventral Hernia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07755657
Acronym
ESPRESSOH
Enrollment
30
Registered
2026-08-10
Start date
2026-03-11
Completion date
2027-12-31
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventral Hernia Repair

Keywords

Ventral hernia repair, da Vinci SP Surgical System, Extraperitoneal

Brief summary

Evaluation of the perioperative outcomes of robotic suprapubic ventral hernia repair with the Da Vinci Singe Port (SP) system

Detailed description

Ventral hernia repair using mesh reinforcement is recommended for primary ventral hernias larger than 1 cm. Robotic-assisted techniques may facilitate extraperitoneal mesh placement and improve surgical precision. The da Vinci Single Port (SP) system enables robotic surgery through a single incision and may further reduce invasiveness while improving cosmetic outcomes. The ESPRESSOH study is a single-centre, single-arm prospective cohort study evaluating a novel robotic suprapubic extraperitoneal single-port technique (SP2 eTEP) for ventral hernia repair, with or without concomitant diastasis repair. The study aims to assess perioperative outcomes, safety, technical feasibility, patient-reported quality of life and body image, and hernia recurrence following surgery performed with the da Vinci SP system. Participants will be followed for one year after surgery.

Interventions

PROCEDURESP2 eTEP

Participants undergo robotic suprapubic ventral hernia repair using the SP2 eTEP (suprapubic extraperitoneal single-port enhanced-view totally extraperitoneal) technique with the da Vinci Single Port surgical system. The procedure includes extraperitoneal mesh placement for repair of primary ventral hernias, with or without concomitant diastasis repair.

Robotic surgical platform used to perform the SP2 eTEP ventral hernia repair procedure through a single suprapubic incision.

Sponsors

Algemeen Ziekenhuis Maria Middelares
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults with a primary midline ventral (umbilical or epigastric) classified as M1-M4 according to EHS classification with or without concomitant diastasis of the rectus abdominis muscles

Exclusion criteria

* Post-prostatectomy * Post-preperitoneal mesh operation for inguinal hernia * Laparotomy in the lower abdomen * Caesarean section * Pregnancy * Contra-indication for general anaesthesia

Design outcomes

Primary

MeasureTime frameDescription
Operative TimeDuring surgeryDuration of the robotic suprapubic ventral hernia repair procedure.
Technical Errors With the Robotic SystemDuring surgeryNumber and type of technical errors or device-related issues encountered during the procedure.
Complication RateFrom surgery until 1 month postoperativelyIntraoperative, in-hospital and postoperative complications classified according to the Clavien-Dindo classification.

Secondary

MeasureTime frameDescription
EuraHS Quality of Life ScorePreoperatively, 1 month and 1 year postoperativelyPatient-reported quality of life assessed using the European Registry for Abdominal Wall Hernias Quality of Life (EuraHS-QoL) Questionnaire, a validated instrument evaluating pain at the hernia site, restriction of activities, and cosmetic discomfort. The total EuraHS-QoL score ranges from 0 to 90, with lower scores indicating better quality of life and less symptom burden, and higher scores indicating worse quality of life and greater symptom burden.
Body Image Questionnaire ScorePreoperatively, 1 month postoperatively, and 1 year postoperativelyPatient-reported body image assessed using the Body Image Questionnaire. The questionnaire evaluates patient satisfaction with physical appearance and cosmetic outcomes following robotic ventral hernia repair.
Hernia Recurrence Rate1 year postoperativelyPresence of recurrent ventral hernia assessed clinically and confirmed by ultrasound when clinically indicated.

Countries

Belgium

Contacts

CONTACTFilip Muysoms, MD, PhD
filip.muysoms@gmail.com+32477325710
PRINCIPAL_INVESTIGATORFilip Muysoms, MD, PhD

Algemeen Ziekenhuis Maria Middelares

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026